|
Originally published In Press as doi:10.1074/jbc.M102385200 on February 5, 2002
J. Biol. Chem., Vol. 277, Issue 19, 16470-16477, May 10, 2002
Localization of Microsomal Triglyceride Transfer Protein in
the Golgi
POSSIBLE ROLE IN THE ASSEMBLY OF CHYLOMICRONS*
Emile
Levy §,
Simona
Stan ,
Edgard
Delvin¶,
Daniel
Ménard ,
Carol
Shoulders**,
Carole
Garofalo ,
Isabelle
Slight ,
Ernest
Seidman ,
Gaétan
Mayer§§, and
Moïse
Bendayan§§
From the Departments of Nutrition,
¶ Biochemistry,  Pediatrics, and
§§ Pathology and Cell Biology, Hôpital
Sainte-Justine and University of Montreal, Montreal, Quebec H3T 1C5,
Canada, Group on the Functional Development and Physiopathology
of the Digestive Tract, Canadian Institute of Health Research and
Department of Cellular Biology, Faculty of Medicine, Université
de Sherbrooke, Sherbrooke, Quebec J1H 5N4, Canada, and the
** Department of Medicine, Hammersmith Hospital,
London W12 0NN, United Kingdom
Received for publication, March 16, 2001, and in revised form, December 31, 2001
 |
ABSTRACT |
Although a critical role of
microsomal transfer protein (MTP) has been recognized in the assembly
of nascent apolipoprotein B (apoB)-containing lipoproteins, it remains
unclear where and how MTP transfers lipids in the secretory
pathway during the maturational process of apoB lipidation. The aims of
this study were to determine whether MTP functions in the secretory
pathway as well as in the endoplasmic reticulum and whether its
large 97-kDa subunit interacts with the small 58-kDa protein disulfide
isomerase (PDI) subunit and apoB, particularly in the Golgi apparatus.
Using a high resolution immunogold approach combined with specific
polyclonal antibodies, the large and small subunits of MTP were
observed over the rough endoplasmic reticulum and the Golgi. Double
immunocytochemical detection unraveled the colocalization of MTP and
PDI as well as MTP and apoB in these same subcellular compartments. To
confirm the spatial contact of these proteins, Golgi fractions were
isolated, homogenized, and incubated with an anti-MTP large subunit
antibody. Immunoprecipitates were applied on SDS-PAGE and then
transferred on to nitrocellulose. Immunoblotting the membrane with PDI
and apoB antibodies confirmed the colocalization of these proteins with
MTP. Furthermore, MTP activity assay disclosed a substantial triglyceride transfer in the Golgi fractions. The occurrence of membrane-associated apoB in the Golgi, coupled with its interaction with active MTP, suggests an important role for the Golgi in the biogenesis of apoB-containing lipoproteins.
 |
INTRODUCTION |
Lipids constitute the most calorically dense dietary nutrients.
They must undergo emulsification within the intestinal lumen, cell
membrane permeation, intracellular esterification, and incorporation into chylomicrons before reaching the circulatory system (for reviews, see Refs. 1-4). Despite significant progress, our
understanding of the complex biosynthetic process involved in the
formation and secretion of triglyceride-rich lipoprotein particles
remains rather fragmentary. In particular, we know little about the
sequential multistep assembly of apolipoproteins and lipids or the
topology of the proteins in intracellular organelles implicated in
lipoprotein production.
The study of naturally occurring mutations and genetic variations in
humans has greatly contributed to the identification of the proteins
essential to the synthetic pathway and to the delineation of key
metabolic mechanisms (5-11). Inherited disorders of apolipoprotein B
(apoB)1 and microsomal
transfer protein (MTP) deficiency have provided a unique source for
delineating, at least partially, the role of these specific proteins as
well as elucidating the intracellular mechanisms that result in lipid
absorption and transport (5-11). The addition of core lipid to the
nascent lipoprotein particle is thought to occur in conjunction with
the translation and translocation of apoB in the ER (12-15). During
this process, apoB remains tightly bound to the ER membrane, where it
is folded. The initial complement of lipid is then added to form a
nascent, small, dense lipoprotein particle. In the second step,
maturation of the particle occurs by the addition of the neutral lipid
core (16, 17). Based upon the known lipid transfer activity of MTP, its
localization in the lumen of the ER, and the observation that apoB is
degraded intracellularly and not secreted in the absence of MTP, it has been proposed that MTP shuttles lipids from the ER membrane to the
growing apoB chain in the ER, allowing the protein to translocate completely into the lumen (18-20). However, very little is known about
where and how the addition of bulk lipids to the nascent particle takes place.
Several models have been proposed for the formation of VLDL:
(a) complete assembly of VLDL in the ER (21-23);
(b) association of apoB with membranes until it reaches the
Golgi apparatus, whereupon lipid is added to the particle (24, 25); and
(c) a sequential addition of lipid to apoB during its
passage from the ER to the Golgi for secretion (26-28). If partial
assembly takes place in the Golgi and additional core lipids and
phospholipids are added in the pre-Golgi and Golgi as has been
suggested (25, 29), one would anticipate the obligatory presence of MTP
in these compartments.
Structurally, MTP is a heterodimer composed of a unique large subunit
(97 kDa) and a smaller subunit (58 kDa) (30-33). The latter has been
identified as the multifunctional enzyme, protein disulfide isomerase
(PDI). The role of PDI in the function of MTP is not entirely clear.
The two subunits form a tight complex, and their dissociation
eliminates MTP activity. The intracellular location of MTP in the
intestine has not been thoroughly elucidated. Subfractionation of crude
liver homogenates suggested that MTP is located in hepatocellular
microsomes (32, 33). Nevertheless, this finding was not confirmed by
immunoelectron microscopy. In the present paper, the following issues
are addressed. 1) Can MTP be found in secretory pathway sites other
than the ER? 2) Does it occur alone or in close proximity to PDI in
these compartments? 3) Does it colocalize with apoB? 4) If MTP can be
detected in the Golgi apparatus, is it functional? 5) Can it facilitate
apoB translocation from Golgi membranes? The answers to these questions provided by the experiments described herein help elucidate the mechanisms involved in the assembly and secretion of apoB-containing lipoproteins.
 |
MATERIALS AND METHODS |
Intestinal Specimens--
Sprague-Dawley rats were used for all
experiments. Jejunal specimens were taken at the ligament of Treitz,
washed, and prepared for microscopy visualization. For the isolation of
Golgi, the mucosa was scraped, homogenized, and ultracentrifuged.
Tissue Preparation for Electron Microscopy--
Intestinal
specimens were fixed by immersion in 1% glutaraldehyde, 0.1 M phosphate-buffered saline (pH 7.4) for 2 h at
4 °C and embedded in Lowicryl K4M at 20 °C according to our
previously described procedures (34). Tissue blocks were examined by
light microscopy to select well oriented villus tips. Thin sections (60-80 nm) of the different tissue blocks were mounted on nickel grids
with a carbon-coated Parlodion film and processed for immunocytochemistry.
Immunocytochemical Labeling--
Protein A-gold
immunocytochemical techniques were employed to detect the presence of
MTP, PDI, and apoB in rat intestinal tissue as we have described
previously (34, 35). Briefly, the tissue sections were washed initially
in distilled water, incubated for 5 min on a drop of PBS containing 1%
ovalbumin, and transferred subsequently to a drop of the PBS-diluted
antibody (see below). After incubation (90 min) at room temperature,
the grids were rinsed with PBS to remove unbound antibodies. They were
transferred to the PBS-ovalbumin (3 min) and incubated on a drop of
protein A-gold (pH 7.2) for 30 min at room temperature. The tissue
sections were then thoroughly washed with PBS, rinsed with distilled
water, and dried. Sections were stained with uranyl acetate and lead
citrate before examination with a Philips 410 electron microscope.
Polyclonal antibodies were used at various dilutions (MTP 1/100, MTP
large subunit 1/50, PDI 1/10, apoB 1/100) in combination with protein
A-gold complexes, which were prepared using 10- or 5-nm gold particles
according to our established techniques (35, 36). Control experiments
were performed to assess the specificity of the results. Excess
purified MTP (10-fold) was added to the antibody solution.
Incubation with this solution was followed by the protein A-gold
complex. Pre-immune rabbit serum (diluted 1:10) was used on tissue
sections before incubation with protein A-gold complex. Incubations
were also performed with the protein A-gold complex alone, omitting the
antibody step to test for nonspecific adsorption of the protein A-gold
complex to tissue sections (36).
Double-labeling Technique--
To reveal the existence of
MTP-PDI as well as MTP-ApoB complexes within the cellular compartments,
the double-labeling technique was applied. The tissue sections were
labeled simultaneously for either MTP and PDI or MTP and ApoB. The
two-phase labeling technique (36, 37) was applied to avoid any
cross-reaction between reagents. The small protein A-gold complex (5 nm) was used for the first labeling protocol, and the larger 10 nm
protein A-gold complex was used for the second. This protocol allows
for the simultaneous visualization of two antigens (MTP and PDI or MTP
and ApoB) in the same tissue section.
Antibodies--
The antibodies for the MTP, PDI, and MTP large
subunits were kindly provided by John Wetterau, Harris Jamil,
and one of the authors (C. Shoulders). These antibodies have been
characterized and utilized successfully in previous studies (7, 31, 38, 39). The antibody directed against rat apoB was raised in rabbits (35).
Confirmation of the specificity of the antibodies was obtained when: 1)
MTP large and small subunits as well as apoB from total homogenate were
fractionated by SDS-PAGE, transferred to nitrocellulose, and
immunoblotted with each polyclonal antibody; and 2) cellular lysates
were first reacted with the antibodies (directed against large MTP
subunit, small MTP subunit, and apoB antibodies) before the
immunoprecipitates were subjected to gel electrophoresis, transferred
to nitrocellulose membranes, and reacted with the underlying antibodies.
Microsomes and Golgi Fractions--
Microsomal and Golgi
fractions were prepared from enterocytes of fasted rats using
modifications of reported techniques (40, 41). Epithelial cells were
homogenized (25%, w/v) in 0.25 M sucrose in buffer (50 mM Tris-HCl, pH 7.4, and 25 mM KCl) containing protease inhibitors (10 µg/ml leupeptin, 10 µg aprotinin, 1 µg/ml pepstatin, 1 µg/ml antipain, and 25 mM
4-aminophenyl-methanesulfonyl fluoride) using a polytron (Brinkmann
Instruments) at a setting of 1 (30 s). The homogenate from a group of
animals was used to prepare microsomes representative of the
endoplasmic reticulum (40). For the preparation of Golgi fractions, the
homogenate from another group of animals was filtered through
cheesecloth and then adjusted (150 parts homogenate and 95 parts 2 M sucrose in the aforementioned buffer) to a final
concentration of 1.07 M sucrose. The adjusted homogenate
(19 ml/tube) was loaded into Beckman SW 28 tubes; 9 ml each of 0.9 and
0.2 M sucrose in the aforementioned buffer were then
sequentially overlaid above the homogenate. The tubes were subsequently
centrifuged in an SW 28 rotor for 2 h at 83,000 × g. Golgi fractions were collected at the 0.2/0.9
M sucrose interface.
To prepare Golgi membranes, Golgi fractions were mixed 1:1 (v/v) with
the buffer (50 mM HEPES, pH 7.4, 100 mM KCl,
and the protease inhibitors as indicated above) with 20% glycerol and centrifuged for 90 min at 200,000 × g. Golgi membrane
pellets were resuspended at 5% of their original volume in 0.25 M sucrose in the same buffer. Golgi membranes were
solubilized with either 1% Igepal CA 630 (a Nonidet P-40 equivalent
from Sigma) or 1% CHAPS and 0.2% Triton X-100-containing buffer. The
extract was then centrifuged at 200,000 × g, and the
pellet was discarded. The purity of the Golgi subcellular fraction was
verified by assay of galactosyltransferase, a specific marker for Golgi
organelles, and glucose-6-phosphatase, a marker for the ER.
Purification of Transfer Protein--
The intestinal ER and
Golgi specimens were sonicated in 1 ml of 10 mM phosphate
buffer (pH 6.8) containing saponin (100 µg/ml) and protease
inhibitors (leupeptin, 10 µg/ml; Trasylol, 10 µg/ml; pepstatin A, 1 µg/ml). The MTP/PDI heterodimer was separated by ultracentrifugation
(100,000 × g) and concentrated using a Centricon 30 cartridge (5000 rpm × 30 min).
MTP Activity Assay--
The triglyceride transfer assay was
adapted from previous reports (30, 39, 42). The MTP transfer activity
was determined by evaluating the transfer of radiolabeled
triacylglycerol between two populations of unilamellar vesicles as
described (30, 39, 43). The donor and receiver vesicles were prepared
by adding the appropriate amount of lipids to 500 µl of chloroform
followed by drying under a stream of nitrogen, rehydration, and probe
sonication in 1.25 ml of 15:35 buffer (15 mM Tris/HCl, pH
7.4, 35 mM NaCl, 0.05% bovine serum albumin, 3 mM sodium azide, 1 mM EDTA). Donor vesicles
contained, per assay, 4 nmol of egg yolk phosphatidylcholine, 0.33 nmol
of cardiolipin, and 0.024 nmol of [3H]trioleylglycerol
(Amersham Biosciences). Receptor vesicles contained 24 nmol of egg yolk
phosphatidylcholine, 0.048 nmol of trioleylglycerol, and ~4000 cpm of
[14C]dipalmitoyl phosphatidylcholine
([14C]DPPC; Amersham Biosciences). Both categories of
vesicles comprised 0.01% butylated hydroxytoluene. Various amounts of
semi-purified MTP were incubated with 5 µl of donor and receptor
vesicles in a final volume of 100 µl for 1 h at 37 °C. The
reaction was quenched by adding 400 µl of ice-cold 15:35 buffer
(without bovine serum albumin). The negatively charged (due to the
presence of cardiolipin) donor vesicles were removed from the reaction
mixture by adsorption onto DEAE-cellulose (Whatman DE-52). The
supernatant (containing the receptor vesicles) was collected after a
low speed centrifugation (13000 × g) and recentrifuged
(13000 × g) to assure a total removal of the
DEAE-cellulose before scintillation counting. A blank assay containing
donor and acceptor membranes without transferred protein was used to
correct for the spontaneous transfer of labeling between vesicles. The
ratio of [3H]glycerol trioleate on
[14C]dipalmitoyl phosphatidylcholine was determined, and
the percentage lipid transfer was calculated from the increase in this
ratio. Lipid transfer activity was determined from the initial linear portions of the activity curves.
In Vitro Experiments with BMS-200150--
ApoB synthesis was
assessed in everted rat intestine, as described previously (44).
Then, 300 µCi of [35S]methionine was added to the RPMI
1640 medium for 1 h. The medium was removed, and the intestine was
washed and again incubated for 2 h with medium containing 10 mM unlabeled methionine in the presence or absence of 15 µM BMS-200150, an inhibitor of MTP. Labeled apoB from
membranes and the luminal contents of isolated microsomal and Golgi
fractions were immunoprecipitated, subjected to SDS-PAGE
electrophoresis, excised from the gel, and counted (45).
 |
RESULTS |
The first step in our studies was to test the specificity of the
polyclonal antibodies that were generously provided by investigators (see "Acknowledgments") who remarkably advanced the
knowledge of MTP. By immunoprecipitating epithelial cell lysates,
separating the immunoprecipitates on SDS-PAGE, and Western blotting
them separately with large 97-kDa and small 58-kDa antibodies, we
identified the expected 97- and 58-kDa subunits corresponding to the
MTP and PDI components, respectively (Fig.
1A). The use of polyclonal antibodies directed against the whole MTP complex resulted in the
recovery of both MTP and PDI subunits (Fig. 1A). Similar
experimental procedures displayed and confirmed the specificity of
anti-apoB antibodies (Fig. 1A). In a second step, the
specificity of antibodies was verified by fractionating the total
homogenate by SDS-PAGE, transferring it to nitrocellulose, and
immunoblotting. Once again, we found only the signal corresponding to
the targeted protein (Fig. 1B).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 1.
Antibody specificity. Two techniques
were utilized. A, cellular lysates were reacted separately
with the antibodies directed against MTP, PDI, and apoB. The
immunoprecipitates were subjected to gel electrophoresis and
transferred to nitrocellulose membranes. Thereafter, the latter were
blotted with large 97-kDa MTP subunit antibodies, small 58-kDa MTP
subunit (PDI) antibodies, or apoB antibodies. B,
homogenate was fractionated by SDS-PAGE, transferred to nitrocellulose,
and immunoblotted with each polyclonal antibody. Molecular size
standards (ST) were used to identify the location of the
proteins.
|
|
We subsequently used immunocytochemical techniques and isolated
microsomal and Golgi fractions to reveal the presence of MTP in these
subcellular compartments. The purity of microsomal and Golgi fractions
was determined by the assay of galactosyltransferase, as a specific
marker for Golgi membranes, and glucose-6-phosphatase as a marker for
the ER. The results of marker protein assays from a typical
fractionation are shown in Table I. The
Golgi fraction was enriched 96-fold with UDP-galactose
galactosyltransferase specific activity over cell homogenate, whereas
glucose-6-phosphatase activity was very low (1.26-fold) in this cell
organelle. Furthermore, the rough ER-derived fraction was enriched
3.8-fold in the specific activity of glucose-6-phosphotase and
2.46-fold in that of galactosyltransferase.
View this table:
[in this window]
[in a new window]
|
Table I
Specific activities of marker enzymes of subcellular fractions
Microsomal and Golgi subcellular fractions were prepared as described
under "Materials and Methods." The purity of the organelle
fractions was assessed by determining the specific activities of
UDP-galactose galactosyltransferase and glucose-6-phosphatase. The
enrichment of the marker enzymes in each cellular fraction was
calculated by dividing the specific activity of the subcellular
fraction by that of the homogenate (data are given in parentheses). The
data represent the average of n = 2.
|
|
Immunocytochemical Detection of MTP and PDI--
An anti-MTP
heterodimer antibody was initially applied to define the
immunocytochemical pattern of labeling in enterocytes (Fig.
2). The ultrastructural analysis of rat
enterocytes revealed significant labeling over the rough ER, the Golgi
area, and basolateral membranes (Fig. 2). The trans-Golgi cisternae
were more intensely labeled. Finally, the gold particles in the basal
region of the enterocyte were associated with the basolateral
membrane and its interdigitations (Fig. 2). Only very few particles
were located over the mitochondria and nuclei.

View larger version (156K):
[in this window]
[in a new window]
|
Fig. 2.
Immunocytochemical detection of MTP in rat
enterocytes. Protein A-gold immunocytochemical technique was
applied with the polyclonal antibody directed against the heterodimer
MTP/PDI to localize it in absorptive cells of rat jejunum. The labeling
by gold particles revealed the antigenic sites of the MTP/PDI
heterodimer at the level of the rough ER (RER), Golgi
apparatus (G) and the basolateral membrane (blm).
Mitochondria (m) and nuclei (N) are devoid of
labeling. Magnification, ×40,000.
|
|
Control experiments confirmed the specificity of these results. The
preadsorbtion of the antibody with its antigen prior to performing
immunocytochemical detection resulted in very low labeling in all
cellular regions (Fig. 3). Similar data
were obtained with the other control experiments, confirming the
validity of the morphological findings. Furthermore, the addition of
albumin to the antibody solution did not alter the pattern of
labeling.

View larger version (169K):
[in this window]
[in a new window]
|
Fig. 3.
Assessment of labeling specificity. The
tissue section was incubated with antigen-adsorbed antibody against the
MTP large subunit followed by the protein A-gold complex. The labeling
by gold particles was drastically reduced, with very few particles
present over the different cellular compartments. G, Golgi
apparatus; RER, rough endoplasmic reticulum; m,
mitochondria. Magnification, ×30,000.
|
|
The antibody used in this first series of experiments recognizes the
whole 97-kDa-58-kDa MTP protein complex. We therefore attempted to
distinguish between the two subunits by employing antibodies specific
to the 97-kDa and the 58-kDa polypeptides separately. With the antibody
directed against the MTP large subunit, the distribution of the
labeling (Fig. 4) over the rough ER and the Golgi apparatus was qualitatively identical to that recorded for
the entire MTP complex, as illustrated in Fig. 2. A similar distribution was observed when anti-PDI antibody was utilized (Fig.
5). Again, negligible labeling was noted
with control experiments (data not shown).

View larger version (167K):
[in this window]
[in a new window]
|
Fig. 4.
Immunocytochemical detection of the MTP large
subunit in rat jejunal enterocytes. A specific polyclonal antibody
directed against the 97-kDa large subunit of MTP was employed in
combination with protein A-gold. Labeling is present over the rough ER
(RER) and the Golgi area (G) including small
vesicles (v). Mitochondria (m) are devoid of
labeling. Magnification: A, ×50,000; B,
×30,000.
|
|

View larger version (113K):
[in this window]
[in a new window]
|
Fig. 5.
Immunocytochemical detection of PDI in rat
jejunal enterocytes. Protein A-gold was used in combination with a
specific polyclonal antibody directed against the small 57-kDa PDI
subunit of MTP. Labeling is present over the rough ER (RER),
the Golgi apparatus (G), and the basolateral membrane
(blm). Magnification, ×30,000
|
|
Double Immunocytochemical Detection of MTP and PDI as Well as MTP
and ApoB--
The interaction of MTP with PDI is required for the
production of the soluble, active MTP complex (33), which in turn is crucial for the assembly of apoB-containing lipoproteins (7, 8, 18,
19). In addition to demonstrating their labeling in the secretory
pathway, as described above, we assessed their ultrastructural
colocalization using double immunocytochemical detection. MTP was
revealed by 10-nm protein A-gold, and PDI was shown using 5-nm protein
A-gold (Fig. 6). Both particles were present over the rough ER and the Golgi area, many of them in very
close association. Only very few gold particles were detected over the
nuclei and mitochondria. These data provide evidence for the presence
of MTP-PDI complexes not only in rough ER but also in the Golgi
apparatus.

View larger version (161K):
[in this window]
[in a new window]
|
Fig. 6.
Double immunocytochemical detection of the
MTP large subunit and PDI using corresponding specific antibodies and
protein A-gold complexes of different sizes. MTP large subunit is
revealed by 10-nm protein A-gold, whereas PDI is visualized by 5-nm
protein A-gold. Labeling for both antigens is present in the rough
endoplasmic reticulum (RER), Golgi (G), and
basolateral membrane (blm). The association of both antigens
is revealed by the formation of large and small gold particle doublets
(some have been circled). Mitochondria (m) and
nuclei (N) are devoid of labeling. Magnification:
A, ×50,000; B, ×30,000.
|
|
Double immunocytochemical detection of the large subunit of MTP and
apoB was also investigated in the rat jejunal enterocytes (Fig.
7). MTP and apoB were revealed by 10- and
5-nm protein A-gold complexes, respectively. Numerous doublets, formed
by large and small gold particles, were found over the Golgi area,
suggesting that MTP and apoB are colocalized and associated in the same
cellular compartments of the enterocyte. It must be noted that only a
certain percentage of the gold particles revealing a large MTP subunit or PDI appeared to be colocalized. This may be due to numerous factors
such as the ubiquitous nature of PDI, which fulfills various functions
in other locations intrinsic to the ER, and technical limitations
stemming from immunogold itself.

View larger version (128K):
[in this window]
[in a new window]
|
Fig. 7.
Double immunocytochemical detection of MTP
large subunit and apoB using the corresponding specific antibodies and
the protein A-gold complexes formed by large and small gold
particles. MTP large subunit is revealed by 10-nm protein A-gold,
whereas apoB is detected by 5-nm protein A-gold complex. Labeling for
both antigens is present over the Golgi apparatus (G). The
association of both antigens is revealed by the formation of large and
small gold particle doublets (some of which are circled).
Magnification, ×45,000.
|
|
Interaction of MTP Large Subunit with PDI and ApoB in the
Golgi--
The aforementioned ultrastructural studies demonstrated the
presence of MTP complex and the colocalization of its two subunits in
the Golgi apparatus. Additional studies were carried out to assess its
function in this subcellular compartment. Because the association of
PDI (58 kDa) with MTP large subunit (97 kDa) is necessary to maintain
the catalytically active form of the triacylglycerol transfer protein
and to prevent the aggregation of the 97-kDa component, we examined
their physical interaction. For this purpose, Golgi fractions were
isolated and homogenized in a nondenaturing buffer. Immunoprecipitation
was also carried out with an anti-MTP large subunit antibody under
nondenaturing conditions. The immunoprecipitates were run onto SDS-PAGE
and transferred to a nitrocellulose membrane. Immunoblotting the
membrane with anti-PDI antibody confirmed the presence of PDI (Fig.
8A). Thus, the anti-MTP large
subunit appeared to precipitate PDI, whereas MTP antibodies recognized
the MTP large subunit (Fig. 8B), indicating an interaction
between the MTP large subunit and PDI in the Golgi. In a second step,
MTP activity was measured after setting up the assay in order to
defining the optimal conditions; i.e. incubation time,
protein linearity, background transfer in the absence of MTP, and
recovery of acceptor vesicles. The assay disclosed substantial
triacylglycerol transfer activity in the Golgi fraction compared
with that of microsomes (Fig. 9).
Together these findings indicate that the MTP complex is present in the
Golgi and that it maintains its capacity to transfer triacylglycerol in
that organelle. Finally, based on the protein recovery of isolated
organelles, intestinal microsomes and Golgi fractions represented 64 and 46%, respectively, of the total cellular MTP activity.

View larger version (76K):
[in this window]
[in a new window]
|
Fig. 8.
Association of MTP large subunit with apoB
and PDI in the Golgi. Golgi were disrupted with a nondenaturing
buffer and immunoprecipitated with nonimmune serum or anti-MTP large
subunit antibody (a-MTP (ls)). The
immunoprecipitates were run on SDS-PAGE and transferred to a
nitrocellulose membrane. The membrane was blotted with anti-PDI
antibody (A), anti-MTP large subunit antibody
(B), or anti-apoB antibody (C). In panel
A, immunoblotting with anti-PDI antibody demonstrated that PDI
co-precipitates by using anti-MTP large subunit antibody. In
panel B, immunoblotting with anti-MTP large subunit antibody
demonstrated that the MTP large subunit was immunoprecipitated using
anti-MTP large subunit. In panel C, immunoblotting with
anti-apoB antibody revealed that apoB co-immunoprecipitated with the
large subunit of MTP.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 9.
MTP activity in the Golgi fraction isolated
from the enterocytes of rat jejunum. Microsomal and Golgi
fractions were prepared as described under "Materials and Methods."
MTP was quantified by measuring the rate of transfer of
3H-labeled triglyceride from donor vesicles to acceptor
vesicles prepared as reported under "Materials and Methods." The
percentage of total activity (in histograms) was calculated as the
proportion of the sum of microsomes and Golgi.
|
|
Immunoblotting experiments were performed to confirm the spatial
contact of MTP with apoB in the Golgi fractions. Immunoprecipitation was carried out with the antibody directed against the large MTP subunit. The immunoprecipitates were run on SDS-PAGE and transferred onto a MTP nitrocellulose membrane. The latter was blotted with anti-apoB antibodies. As shown in Fig. 8C, no apoB was
visualized with nonimmune sera, whereas it was clearly detected with
anti-apoB antibody. These observations are consistent with the
aforementioned ultrastructural findings illustrating the colocalization
of MTP with apoB.
Finally, Golgi fractions were exposed to nonimmune serum or
anti-apoB antibodies. The immunoprecipitate was run on SDS-PAGE and
transferred onto a nitrocellulose membrane. The membrane was blotted
with MTP large subunit antibody. MTP large subunit (97 kDa) was
detected in the anti-apoB immunoprecipitate but not in the nonimmune
precipitate (Fig. 10).

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 10.
Precipitation of MTP large subunit with apoB
antibodies. Golgi homogenate was immunoprecipitated with either
nonimmune serum or anti-apoB antiserum (a-apo B). The
immunoprecipitates were run on SDS-PAGE and transferred to a
nitrocellulose membrane. The membrane was blotted with anti-MTP large
subunit (MTP (ls)).
|
|
Presence of ApoB in the Golgi Membrane--
The presence of apoB
in the Golgi may be derived from apoB-containing lipoprotein transit
from the rough ER or from its close association with the Golgi
membrane. To demonstrate that apoB is a resident membrane protein of
the Golgi apparatus, membranes were isolated, immunoprecipitated with
anti-apoB antiserum, applied on SDS-PAGE, and transferred onto a
nitrocellulose membrane. Again, we used galactosyltransferase as a
marker of Golgi membranes, and the overall enrichment of its
specific activity was 133-fold. Anti-apoB antibodies revealed the
presence of apoB, suggesting that apoB is associated with Golgi
membranes (Fig. 11).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 11.
ApoB location in Golgi membranes. Golgi
membranes were prepared and incubated with nonimmune serum (lane
1) or anti-apoB antiserum (lanes 2-4). The
immunoprecipitates were run on SDS-PAGE and transferred to a
nitrocellulose membrane. The membrane was blotted with anti-ApoB
antiserum.
|
|
Elimination of Any Possibility of MTP Leakage from the ER to the
Golgi--
Immunocytochemical labeling has demonstrated the presence
of MTP not only in the ER but also in the Golgi apparatus. To
demonstrate that the finding of MTP in the Golgi is not merely the
result of leakage from the ER, two approaches were adopted. First, a quantitative estimation was achieved in order to compare protein enrichment in the Golgi and ER. To this end, about 50 fields from the
Golgi-ER area were examined at ×16,500 magnification, and MTP labeling
densities in each cellular compartment were evaluated by morphometric
methods (36). The calculated mean ratio value between the Golgi and ER
was found to be 2.72, showing MTP enrichment in the Golgi apparatus and
the concentration process taking place in this organelle. Second, an
ER-resident protein, namely the Grp78 (Bip), was revealed by
immunocytochemistry. Specific labeling was obtained over the rough ER
of the enterocytes, whereas only a very few gold particles were
detected at the level of the Golgi apparatus (results not shown),
confirmed by the calculated mean ration value (0.33) between the Golgi
and ER labeling. Altogether, these data indicate that leakage from the
ER to the Golgi is negligible.
Role of MTP in ApoB Movement--
In further experiments, we
investigated the effects of MTP inactivation by BMS-200150 on the
behavior pattern of newly synthesized apoB in the membranes and
on the luminal contents of both microsomal and Golgi fractions (Table
II). ApoB disappeared more rapidly from
the microsomal and Golgi membranes after a 2-h chase period than after
a 1-h pulse. However, with the inactivation of MTP, a delay was noted
in the removal of newly synthesized apoB from microsomal and Golgi
membranes. In addition, little effect of the MTP inhibitor was observed
on the disappearance of apoB from the lumen of the two subcellular
compartments. These experiments suggest that MTP protects apoB against
co-translational degradation.
View this table:
[in this window]
[in a new window]
|
Table II
Effect of MTP inhibitor on apoB from the microsomal and Golgi
membranes and lumen
Intestinal everted sacs were pulse-labeled with
[35S]methionine for 1 h and chased for 2 h either
in the presence or the absence of BMS-200150. The subcellular
organelles (microsomes and Golgi) were prepared, and labeled apoB was
determined in isolated membranes and luminal contents. The results are
the mean of two experiments (presented in parentheses).
|
|
 |
DISCUSSION |
Most of the studies undertaken to delineate the role of MTP in the
assembly of apoB-containing lipoproteins have suggested that the ER
represents its site of action in view of its involvement in the
biogenesis of triglyceride-rich lipoproteins. It was previously unknown
whether MTP is found in other subcellular organelles in the small gut.
The present investigation examined the intracellular distribution of
the large subunit of MTP along with PDI and apoB in the rat small
intestine. Our data revealed that, at the electron microscope level,
MTP is present particularly in the rough ER and the Golgi apparatus of
the absorptive epithelial cells. Double immunocytochemical labeling
demonstrated the co-localization of the MTP large subunit with PDI and
apoB. The biochemical analyses not only confirmed the ultrastructural
studies but also demonstrated the association between the MTP large
subunit and PDI in the Golgi, the preservation of its transfer
activity, and its interaction with apoB. These observations suggest
that this organelle likely represents a site that is active in
triglyceride-rich lipoprotein assembly.
The PDI and the MTP large subunit are not covalently linked in the
heterodimer, but they form a highly stable protein complex (31). The
spatial contact of the large subunit with PDI is necessary to maintain
the transfer protein in a nonaggregated and catalytically active form
(30-33). The data from the present study documented the presence of
the 58- and 97-kDa subunits of MTP in basolateral membranes. Even if
our ultrastructural experiments showed that the two subunits seem to be
in close physical proximity, we are not able to indicate at this point
whether basolateral membranes contain active MTP. Another puzzling
question is whether MTP accompanies lipoproteins to this subcellular
area. Experiments from our laboratory have shown that freshly isolated
lipoproteins from the blood circulation are devoid of MTP (results not
shown), suggesting that the latter does not exit the cell. Confirming
data were obtained in Caco-2 cells when we were not able to detect any
MTP signal by Western blot or by TG transfer activity at the
basolateral medium. Currently, it is not clear whether the MTP-PDI
complex not only plays a key role in triglyceride-rich lipoprotein
assembly but also functions as a chaperone to facilitate the secretion
of chylomicrons and VLDL.
Much of our knowledge concerning apoB synthesis and lipoprotein
assembly stems from studies using hepatocytes, including human and rat
hepatoma cells, McA-RH7777 cells, and primary hepatocytes (13, 18-20,
46). These hepatic models generally produce both apoB-48 and apoB-100.
The lipidation of apoB is thought to occur in two phases (16, 17).
Initially, the stabilization of apoB necessitates an association with a
small quantity of neutral lipids, which protects it from misfolding and
degradation. The second step is characterized by the bulk transfer of
triacylglycerol to the secretion-competent form of apoB, resulting in
the production of mature particles of VLDL. MTP has been shown to
transport lipid from the ER membrane to apoB in the lumen of the ER (7,
8, 19, 39, 45). This process may be promoted by a physical interaction
between MTP and apoB (46). Our results show that MTP is also located in
the Golgi apparatus of rat intestine in its active form and that it
interacts with apoB locally, as was demonstrated in the ER by Wu
et al. (48) and Patel and Grundy (47).
The requirement for lipid transfer activity in the assembly of
apoB-containing lipoproteins has been underscored by genetic disorders
and various molecular studies. Evidence has been presented for
protein-protein interactions between apoB and MTP, which
may be crucial for the transfer of lipids to apoB during its
translocation or may indicate a chaperone-like activity for MTP in apoB
folding, assembly, and secretion. The binding sites involved in these
interactions have recently been proposed (49, 50). On the other hand,
PDI has been shown to associate with MTP to maintain the MTP complex in
a soluble state (30-33). Because PDI contains the "KDEL" ER retention sequence, it might anchor the MTP complex in the ER at the
site of apoB translocation (51). Additional studies are required to
determine whether most of these events occur in the Golgi apparatus.
The occurrence of membrane-associated apoB in the Golgi, coupled with
its interaction with active MTP, suggests an important role for the
Golgi in the assembly of apoB-containing lipoproteins. Although direct
evidence for such a hypothesis is lacking, earlier reports proposed a
pivotal role for the Golgi in the formation of triglyceride-rich
lipoproteins. Bamberger and Lane (24, 25) reported that ~50% of apoB
is membrane-associated in both the ER and the Golgi in chicken liver.
Using pulse-chase experiments, they concluded that the assembly of
triacylglycerol with apolipoproteins occurs in the Golgi. Similarly,
Higgins (52) suggested that the trans-Golgi region is the
major intracellular site for the assembly of apoB with triacylglycerol
and phospholipid. Furthermore, Olofsson et al. (53)
emphasized that a substantial portion of the oligosaccharide chains of
apoB, along with various posttranslational modifications of both lipid
and apolipoprotein moieties, is processed in the Golgi. Accordingly,
our data showed that MTP inactivation by BMS-200150 delayed the net
removal of newly synthesized apoB from the microsomal and Golgi
membranes but not from the corresponding luminal compartments. Similar
findings were reported in the liver by Hebbachi and colleagues (54,
55). It seems, therefore, that the association of apoB with lipid
components requires active MTP in both the microsomal and Golgi
membranes to allow the secretion-competent form of apoB to form
chylomicrons in the enterocyte. Taken together, these observations
point to the important role of the Golgi in the assembly of
apoB-containing lipoproteins, as suggested by our results herein.
How do our ultrastructural findings and biochemical data fit the
two-phase process for apoB core lipidation? It is possible that nascent
apoB-48 HDL particles, originating in the ER, are supplied with neutral
lipid droplets at the junction of the rough and smooth ER as proposed
by many investigators (for review, see Ref. 4). However, we cannot
exclude the possibility that lipid loading is completed in the Golgi
compartment. During the continuous maturation process, MTP may shuttle
lipids from the Golgi membrane or from locally available lipid droplets
to the growing apoB-containing lipoprotein particles. As noted above, a
considerable body of literature supports a key role of the Golgi in
triglyceride-rich lipoprotein assembly and phospholipid acquisition
(52, 53). On the other hand, we observed the lipid transfer protein
activity of MTP in the Golgi as well as its localization to the lumen
of Golgi and its association with apoB at this site. One may thus suggest that the Golgi apparatus represents an additional site where
MTP enables nascent apoB to attain a secretable conformation by
providing sufficient triacylglycerol for the formation of a neutral
lipid core. The process may be promoted by a physical interaction
between MTP and apoB. This hypothesis is consistent with the recent
observations relative to: (a) the heavy labeling of Golgi
membrane for apoB following radioactivity pulses (54, 55);
(b) Golgi-mediated degradation of apoB (56-58); and
(c) the delay of apoB removal from the Golgi membrane
following MTP inhibition with BMS-200150 (55). In our studies, the
possibility of substantial contamination of Golgi membranes with
microsomes was ruled out by the quantification of marker enzymes (59). Moreover, potential major MTP leakage from the ER to the Golgi apparatus was rejected by appropriate immunocytochemical studies. Thus,
the Golgi may represent an additional important site for lipoprotein
assembly. Nevertheless, many experiments must be carried out to
determine the precise function of MTP in the Golgi and the role in this
organelle in apoB-containing lipoprotein assembly.
In summary, the present investigation demonstrates the presence of MTP
in subcellular compartments associated with the secretory pathway other than the ER. Furthermore, the colocalization of functional MTP and the membrane-associated apoB in the Golgi fraction strongly suggests a role for the Golgi apparatus in the assembly or
maturation of intestinal TG-rich lipoproteins.
 |
ACKNOWLEDGEMENTS |
We thank Drs. J. R. Wetterau and H. Jamil
for the polyclonal antibodies. We also acknowledge the expert
secretarial assistance of Danielle St.-Cyr Huot.
 |
FOOTNOTES |
*
This was supported by research grants from the Canadian
Institutes of Health Research (MT-10583) and the Canadian Heart
Association, as well as research scholarship awards from the
Fonds de la Recherche en Santé du Québec (to E. L.
and E. S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed:
Gastroenterology-Nutrition, Hôpital Sainte-Justine, 3175 Côte Ste.-Catherine, Montreal, Quebec H3T 1C5, Canada. Tel.:
514-345-4626; Fax: 514-345-4999; E-mail:
levye@justine.umontreal.ca.
Published, JBC Papers in Press, February 5, 2002, DOI 10.1074/jbc.M102385200
 |
ABBREVIATIONS |
The abbreviations used are:
apoB, apolipoprotein
B;
MTP, microsomal transfer protein;
ER, endoplasmic reticulum;
VLDL, very low density lipoprotein;
PDI, protein disulfide isomerase;
PBS, phosphate-buffered saline;
CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid.
 |
REFERENCES |
| 1.
|
Davidson, N. O.
(1994)
in
Physiology of Gastrointestinal Tract
(Johnson, L. R., ed), 3rd Ed.
, pp. 1909-1934, Raven Press, New York
|
| 2.
|
Tso, P.
(1994)
in
Physiology of Gastrointestinal Tract
(Johnson, L. R., ed), 3rd Ed.
, pp. 1867-1907, Raven Press, New York
|
| 3.
|
Levy, E.
(1992)
Can. J. Physiol. Pharmacol.
70,
413-419[Medline]
[Order article via Infotrieve]
|
| 4.
|
Hussain, M. M.,
Kancha, R. K.,
Zhou, Z.,
Luchoomun, J., Zu, H.,
and Bakillah, A.
(1996)
Biochim. Biophys. Acta
1300,
151-170[Medline]
[Order article via Infotrieve]
|
| 5.
|
Levy, E.
(1996)
Clin. Invest. Med.
19,
317-324[Medline]
[Order article via Infotrieve]
|
| 6.
|
Levy, E.,
Marcel, R.,
Milne, R. W.,
Grey, V. L.,
and Roy, C.
(1987)
Gastroenterology
93,
1119-1126[Medline]
[Order article via Infotrieve]
|
| 7.
|
Wetterau, J. R.,
Aggerbeck, L. P.,
Bouma, M. E.,
Eisenberg, C.,
Munck, A.,
Hermier, M.,
Schmitz, J.,
Gay, G.,
Rader, D. J.,
and Gregg, R. E.
(1992)
Science
258,
999-1001[Abstract/Free Full Text]
|
| 8.
|
Shoulders, C. C.,
Brett, D. J.,
Bayliss, J. D.,
Narcisi, T. M.,
Jarmuz, A.,
Grantham, T. T.,
Leoni, P. R.,
Bhattacharya, S.,
Pease, R. J.,
Cullen, P. M.,
Levi, S.,
Byfield, P. G. H.,
Purkiss, P.,
and Scott, J.
(1993)
Hum. Mol. Genet.
2,
2109-2116[Abstract/Free Full Text]
|
| 9.
|
Black, D. D.,
Hay, R. V.,
Rohwer-Nutter, P. L.,
Ellinas, H.,
Stephens, J. K,
Sherman, H.,
Teng, B. B.,
Whitington, P. F.,
and Davidson, N. O.
(1991)
Gastroenterology
101,
520-528[Medline]
[Order article via Infotrieve]
|
| 10.
|
Young, S. G.,
Krul, E. S.,
McCormick, S.,
Farese, R. V., Jr.,
and Linton, M. F.
(1996)
Methods Enzymol.
263,
120-145[Medline]
[Order article via Infotrieve]
|
| 11.
|
Wu, J.,
Kim, J., Li, Q.,
Kwok, P.-Y.,
Cole, T. G.,
Cefalu, B.,
Averna, M.,
and Schonfeld, G.
(1999)
J. Lipid Res.
40,
955-959[Abstract/Free Full Text]
|
| 12.
|
Boren, J.,
Graham, L.,
Wettesten, M.,
Scott, J.,
White, A.,
and Olofsson, S.-O.
(1992)
J. Biol. Chem.
267,
9858-9867[Abstract/Free Full Text]
|
| 13.
|
Rustaeus, S.,
Lindberg, K.,
Boren, J.,
and Olofsson, S.-O.
(1995)
J. Biol. Chem.
270,
28879-28886[Abstract/Free Full Text]
|
| 14.
|
Spring, D. J.,
Chem-Liu, L. W.,
Chatterton, J. E.,
Elovson, J.,
and Schumaker, V. N.
(1992)
J. Biol. Chem.
267,
14839-14845[Abstract/Free Full Text]
|
| 15.
|
McLeod, R. S.,
Zhao, Y.,
Selby, S. L.,
Westerlund, J.,
and Yao, Z.
(1994)
J. Biol. Chem.
269,
2852-2862[Abstract/Free Full Text]
|
| 16.
|
Swift, L. L.
(1995)
J. Lipid Res.
36,
395-406[Abstract]
|
| 17.
|
Boren, J.,
Rustaeus, S.,
and Olofsson, S.-O.
(1994)
J. Biol. Chem.
269,
25879-25888[Abstract/Free Full Text]
|
| 18.
|
Gordon, D. A.,
Jamil, H.,
Gregg, R. E.,
Olofsson, S.-O.,
and Boren, J.
(1996)
J. Biol. Chem.
271,
33047-33053[Abstract/Free Full Text]
|
| 19.
|
Wang, Y.,
McLeod, R. S.,
and Yao, Z.
(1997)
J. Biol. Chem.
262,
12272-12278
|
| 20.
|
Benoist, F.,
and Grand-Perret, T.
(1997)
J. Biol. Chem.
272,
20435-20442[Abstract/Free Full Text]
|
| 21.
|
Alexander, C. A.,
Hamilton, R. L.,
and Havel, R. J.
(1976)
J. Cell Biol.
69,
241-263[Abstract/Free Full Text]
|
| 22.
|
Borchardt, R. A.,
and Davis, R. A.
(1987)
Biol. Chem.
262,
16394-16402
|
| 23.
|
Rusinol, A.,
Verkade, H.,
and Vance, J. E.
(1993)
J. Biol. Chem.
268,
3555-3562[Abstract/Free Full Text]
|
| 24.
|
Bamberger, M. J.,
and Lane, M. D.
(1988)
J. Biol. Chem.
263,
11868-11878[Abstract/Free Full Text]
|
| 25.
|
Bamberger, M. J.,
and Lane, M. D.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
2390-2394[Abstract/Free Full Text]
|
| 26.
|
Bostrom, K.,
Boren, J.,
Wettesten, M.,
Sjoberg, A.,
Bondjers, G.,
Wiklund, O.,
Carlsson, P.,
and Olofsson, S. O.
(1988)
J. Biol. Chem.
263,
4434-4442[Abstract/Free Full Text]
|
| 27.
|
Bostrom, K.,
Wettesten, M.,
Boren, J.,
Bondjers, G.,
Wiklund, O.,
and Olofsson, S. O.
(1986)
J. Biol. Chem.
261,
13800-13806[Abstract/Free Full Text]
|
| 28.
|
Janero, D. R.,
and Lane, M. D.
(1983)
J. Biol. Chem.
258,
14496-14504[Abstract/Free Full Text]
|
| 29.
|
Hamilton, R. L.,
Moorehouse, A.,
and Havel, R. J.
(1991)
J. Lipid Res.
32,
529-543[Abstract]
|
| 30.
|
Wetterau, J. R.,
and Zilversmit, D. B.
(1985)
Chem. Phys. Lipids
38,
205-222[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Wetterau, J. R.,
Combs, K. A.,
Spinner, S. N.,
and Joiner, B. J.
(1990)
J. Biol. Chem.
265,
9800-9807[Medline]
[Order article via Infotrieve]
|
| 32.
|
Wetterau, J. R.,
Aggerbeck, L. P.,
Laplaud, P. M.,
and McLean, L. R.
(1991)
Biochemistry
30,
4406-4412[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Wetterau, J. R.,
Combs, K. A.,
McLean, L. R.,
Spinner, S. N.,
and Aggerbeck, L. P.
(1991)
Biochemistry
30,
9728-9735[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Bendayan, M.
(1984)
J. Electron Microsc. Technol.
1,
243-270
|
| 35.
|
Levy, E.,
Rochette, C.,
Londono, I.,
Roy, C. C.,
Milne, R. W.,
Marcel, Y. L.,
and Bendayan, M.
(1990)
J. Lipid Res.
31,
1937-1946[Abstract]
|
| 36.
|
Bendayan, M.
(1995)
Prog. Histochem. Cytochem.
29,
1-163[Medline]
[Order article via Infotrieve]
|
| 37.
|
Bendayan, M.
(1982)
J. Histochem. Cytochem.
30,
81-85[Abstract]
|
| 38.
|
Gordon, D. A.,
Jamil, H.,
Sharp, D.,
Mullaney, D.,
Yao, Z.,
Gregg, R.,
and Wetterau, J.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
7628-7632[Abstract/Free Full Text]
|
| 39.
|
Leiper, J. M.,
Mayliss, J. D.,
Perse, R. J.,
Brett, D. J.,
Scott, J.,
and Shoulders, C. C.
(1994)
J. Biol. Chem.
269,
21951-21954[Abstract/Free Full Text]
|
| 40.
|
Levy, E.,
Garofalo, C.,
Rouleau, T.,
Gavino, V.,
and Bendayan, M.
(1996)
Hepatology
23,
848-857[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Marks, D. L., Wu, K.,
Paul, P.,
Kamisaka, Y.,
Watanabe, R.,
and Pagano, R. E.
(1999)
J. Biol. Chem.
274,
451-456[Abstract/Free Full Text]
|
| 42.
|
Narcisi, T. M.,
Shoulders, C. C.,
Chester, S. A.,
Read, J.,
Brett, D. J.,
Harrison, G. B.,
Grantham, T. T.,
Fox, M. F.,
Povey, S.,
de Bruin, T. W.,
Ekerlens, D. W.,
Muller, D. P. R.,
Lloyd, J. K.,
and Scott, J.
(1995)
Am. J. Hum. Genet.
57,
1298-1310[Medline]
[Order article via Infotrieve]
|
| 43.
|
Wetterau, J. R.,
Lin, M. C. M.,
and Jamil, H.
(1997)
Biochim. Biophys. Acta
1345,
136-150[Medline]
[Order article via Infotrieve]
|
| 44.
|
Levy, E.,
Garofalo, C.,
Thibault, L.,
Dionne, S.,
Daoust, L.,
Lepage, G.,
and Roy, C. C.
(1992)
Am. J. Physiol.
262,
G319-G326[Medline]
[Order article via Infotrieve]
|
| 45.
|
Levy, E.,
Sinnett, D.,
Thibault, L.,
Nguyen, T. D.,
Delvin, E.,
and Ménard, D.
(1996)
FEBS Lett.
393,
253-258[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Gibbons, G. F.
(1994)
Curr. Opin. Lipidol.
5,
191-199[Medline]
[Order article via Infotrieve]
|
| 47.
|
Patel, S. B.,
and Grundy, S. M.
(1996)
J. Biol. Chem.
272,
18686-18694
|
| 48.
|
Wu, X.,
Zhou, M.,
Huang, L.-S.,
Wetterau, J.,
and Ginsberg, H. N.
(1996)
J. Biol. Chem.
271,
10277-10281[Abstract/Free Full Text]
|
| 49.
|
Hussain, M. M.,
Bakillah, A.,
Nayak, N.,
and Shelness, G. S.
(1998)
J. Biol. Chem.
273,
25612-25615[Abstract/Free Full Text]
|
| 50.
|
Mann, C. J.,
Anderson, T. A.,
Read, J.,
Chester, S. A.,
Harrison, G. B.,
Köchl, S.,
Ritchie, P. J.,
Bradbury, P.,
Hussain, F. S.,
Amey, J.,
Vanloo, B.,
Rosseneu, M.,
Infante, R.,
Hancock, J. M.,
Levitt, D. G.,
Banaszak, L. J.,
Scott, J.,
and Shoulders, C. C.
(1999)
J. Mol. Biol.
285,
391-408[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Munro, S.,
and Pelham, H. R.
(1987)
Cell
48,
899-907[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Higgins, J. A.
(1988)
FEBS Lett.
232,
405-408[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Olofsson, S. O.,
Bjursell, G.,
Bostron, K.,
Carlsson, P.,
Elovson, J.,
Protter, A. A.,
Reuben, M. A.,
and Bondjers, G.
(1987)
Atherosclerosis
68,
1-17[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
Hebbacchi, A.-M.,
and Gibbons, G. F.
(1999)
Biochim. Biophys. Acta
1441,
36-50[Medline]
[Order article via Infotrieve]
|
| 55.
|
Hebbachi, A.-M.,
Brown, A.-M.,
and Gibbons, G. F.
(1999)
J. Lipid Res.
40,
1758-1768[Abstract/Free Full Text]
|
| 56.
|
Verkade, H. J.,
Fast, D. G.,
Russnol, A. E.,
Scraba, D. G.,
and Vance, D. E.
(1993)
J. Biol. Chem.
268,
24980-24996
|
| 57.
|
Wang, C.-N.,
Hobman, T. C.,
and Brindley, D. N.
(1995)
J. Biol. Chem.
270,
24924-24931[Abstract/Free Full Text]
|
| 58.
|
Fast, D. G.,
and Vance, D. E.
(1995)
Biochim. Biophys. Acta
1258,
159-168[Medline]
[Order article via Infotrieve]
|
| 59.
|
Bruneau, N.,
Lombardo, G.,
Levy, E.,
and Bendayan, M.
(2000)
Microsc. Res. Tech.
49,
329-345[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Leblond, N. G. Seidah, L.-P. Precourt, E. Delvin, M. Dominguez, and E. Levy
Regulation of the proprotein convertase subtilisin/kexin type 9 in intestinal epithelial cells
Am J Physiol Gastrointest Liver Physiol,
April 1, 2009;
296(4):
G805 - G815.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lopez-Parra, E. Titos, R. Horrillo, N. Ferre, A. Gonzalez-Periz, M. Martinez-Clemente, A. Planaguma, J. Masferrer, V. Arroyo, and J. Claria
Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice
J. Lipid Res.,
December 1, 2008;
49(12):
2513 - 2523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Ravid, M. Bendayan, E. Delvin, A. T. Sane, M. Elchebly, J. Lafond, M. Lambert, G. Mailhot, and E. Levy
Modulation of intestinal cholesterol absorption by high glucose levels: impact on cholesterol transporters, regulatory enzymes, and transcription factors
Am J Physiol Gastrointest Liver Physiol,
November 1, 2008;
295(5):
G873 - G885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Levy, K. Trudel, M. Bendayan, E. Seidman, E. Delvin, M. Elchebly, J.-C. Lavoie, L.-P. Precourt, D. Amre, and D. Sinnett
Biological role, protein expression, subcellular localization, and oxidative stress response of paraoxonase 2 in the intestine of humans and rats
Am J Physiol Gastrointest Liver Physiol,
December 1, 2007;
293(6):
G1252 - G1261.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Dashti, M. Manchekar, Y. Liu, Z. Sun, and J. P. Segrest
Microsomal Triglyceride Transfer Protein Activity Is Not Required for the Initiation of Apolipoprotein B-containing Lipoprotein Assembly in McA-RH7777 Cells
J. Biol. Chem.,
September 28, 2007;
282(39):
28597 - 28608.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Mohler, M.-Y. Zhu, A. M. Blade, A.-J. L. Ham, G. S. Shelness, and L. L. Swift
Identification of a Novel Isoform of Microsomal Triglyceride Transfer Protein
J. Biol. Chem.,
September 14, 2007;
282(37):
26981 - 26988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. T. Sane, D. Sinnett, E. Delvin, M. Bendayan, V. Marcil, D. Menard, J.-F. Beaulieu, and E. Levy
Localization and role of NPC1L1 in cholesterol absorption in human intestine
J. Lipid Res.,
October 1, 2006;
47(10):
2112 - 2120.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Siddiqi, S. Siddiqi, J. Mahan, K. Peggs, F. S. Gorelick, and C. M. Mansbach II
The Identification of a Novel Endoplasmic Reticulum to Golgi SNARE Complex Used by the Prechylomicron Transport Vesicle
J. Biol. Chem.,
July 28, 2006;
281(30):
20974 - 20982.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Rava, G. K. Ojakian, G. S. Shelness, and M. M. Hussain
Phospholipid Transfer Activity of Microsomal Triacylglycerol Transfer Protein Is Sufficient for the Assembly and Secretion of Apolipoprotein B Lipoproteins
J. Biol. Chem.,
April 21, 2006;
281(16):
11019 - 11027.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Peretti, C. C. Roy, E. Drouin, E. Seidman, P. Brochu, G. Casimir, and E. Levy
Abnormal intracellular lipid processing contributes to fat malabsorption in cystic fibrosis patients
Am J Physiol Gastrointest Liver Physiol,
April 1, 2006;
290(4):
G609 - G615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Ledford, R. B. Weinberg, V. R. Cook, R. R. Hantgan, and G. S. Shelness
Self-association and Lipid Binding Properties of the Lipoprotein Initiating Domain of Apolipoprotein B
J. Biol. Chem.,
March 31, 2006;
281(13):
8871 - 8876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-M. Li, J. B. Presley, X. Zhang, N. Dashti, B. H. Chung, N. E. Medeiros, C. Guidry, and C. A. Curcio
Retina expresses microsomal triglyceride transfer protein: implications for age-related maculopathy
J. Lipid Res.,
April 1, 2005;
46(4):
628 - 640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Levy, D. Menard, I. Suc, E. Delvin, V. Marcil, L. Brissette, L. Thibault, and M. Bendayan
Ontogeny, immunolocalisation, distribution and function of SR-BI in the human intestine
J. Cell Sci.,
January 15, 2004;
117(2):
327 - 337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Larsson, J. Skogsberg, and J. Bjorkegren
The Low Density Lipoprotein Receptor Prevents Secretion of Dense ApoB100-containing Lipoproteins from the Liver
J. Biol. Chem.,
January 9, 2004;
279(2):
831 - 836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Morel, S. Demignot, D. Chateau, J. Chambaz, M. Rousset, and F. Delers
Lipid-dependent Bidirectional Traffic of Apolipoprotein B in Polarized Enterocytes
Mol. Biol. Cell,
January 1, 2004;
15(1):
132 - 141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Swift, M.-Y. Zhu, B. Kakkad, A. Jovanovska, M. D. Neely, K. Valyi-Nagy, R. L. Roberts, D. E. Ong, and W. G. Jerome
Subcellular localization of microsomal triglyceride transfer protein
J. Lipid Res.,
October 1, 2003;
44(10):
1841 - 1849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zoltowska, E. Ziv, E. Delvin, D. Sinnett, R. Kalman, C. Garofalo, E. Seidman, and E. Levy
Cellular Aspects of Intestinal Lipoprotein Assembly in Psammomys Obesus: A Model of Insulin Resistance and Type 2 Diabetes
Diabetes,
October 1, 2003;
52(10):
2539 - 2545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Marcil, E. Delvin, C. Garofalo, and E. Levy
Butyrate Impairs Lipid Transport by Inhibiting Microsomal Triglyceride Transfer Protein in Caco-2 Cells
J. Nutr.,
July 1, 2003;
133(7):
2180 - 2183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhang and H. Herscovitz
Nascent Lipidated Apolipoprotein B Is Transported to the Golgi as an Incompletely Folded Intermediate as Probed by Its Association with Network of Endoplasmic Reticulum Molecular Chaperones, GRP94, ERp72, BiP, Calreticulin, and Cyclophilin B
J. Biol. Chem.,
February 21, 2003;
278(9):
7459 - 7468.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|